Lithium in Alzheimer's disease: from prevention to treatment

PsychogeriatricsVolume 23, Issue 1 p. 204-205 LETTER TO THE EDITOR Lithium in Alzheimer's disease: from prevention to treatment Antonina Luca, Corresponding Author Antonina Luca [email protected] [email protected] orcid.org/0000-0002-8397-3478 Department Medical, Surgical Sciences and Advanced Technologies, “GF Ingrassia”, University of Catania, Catania, Italy Correspondence: Professor Luca Antonina, MD, PhD, Msc, Department Medical, Surgical Sciences and Advanced Technologies, “GF Ingrassia”, University of Catania. Via Santa Sofia 78, CAP 95131, Catania, Italy. Email: [email protected]; [email protected]Search for more papers by this authorMaria Luca, Maria Luca orcid.org/0000-0002-7190-4889 Centre for Addiction, Catania, ItalySearch for more papers by this author Antonina Luca, Corresponding Author Antonina Luca [email protected] [email protected] orcid.org/0000-0002-8397-3478 Department Medical, Surgical Sciences and Advanced Technologies, “GF Ingrassia”, University of Catania, Catania, Italy Correspondence: Professor Luca Antonina, MD, PhD, Msc, Department Medical, Surgical Sciences and Advanced Technologies, “GF Ingrassia”, University of Catania. Via Santa Sofia 78, CAP 95131, Catania, Italy. Email: [email protected]; [email protected]Search for more papers by this authorMaria Luca, Maria Luca orcid.org/0000-0002-7190-4889 Centre for Addiction, Catania, ItalySearch for more papers by this author First published: 17 November 2022 https://doi.org/10.1111/psyg.12913 Financial disclosures and conflicts of interest: none. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Girlanda F, Cipriani A, Agrimi E et al. Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial. BMC Res Notes 2014; 7: 731. 2Luca A, Calandra C, Luca M. Molecular bases of Alzheimer's disease and neurodegeneration: the role of neuroglia. Aging Dis 2018; 9: 1134– 1152. https://doi.org/10.14336/AD.2018.0201. 3Fajardo VA, Fajardo VA, LeBlanc PJ, MacPherson R. Examining the relationship between trace lithium in drinking water and the rising rates of age-adjusted Alzheimer's disease mortality in Texas. J Alzheimers Dis 2018; 61: 425– 434. https://doi.org/10.3233/JAD-170744. 4Matsunaga S, Fujishiro H, Takechi H. Efficacy and safety of glycogen synthase kinase 3 inhibitors for Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2019; 69: 1031– 1039. https://doi.org/10.3233/JAD-190256. 5Devanand DP, Crocco E, Forester BP et al. Low dose lithium treatment of behavioral complications in Alzheimer's disease: lit-AD randomized clinical trial. Am J Geriatr Psychiatry 2022; 30: 32– 42. https://doi.org/10.1016/j.jagp.2021.04.014. Volume23, Issue1January 2023Pages 204-205 ReferencesRelatedInformation